RNRMarketResearch.com

Lateral Flow Assay Market to 2022 “Investment to Cross US$ 8.24 Billion Driven by Pregnancy, Infectious Disease, Lipid, Cardiac Marker”

Press Release   •   Jan 12, 2018 04:37 EST

Some of major market players in lateral flow assay market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Johnson & Johnson (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and PerkinElmer, Inc. (U.S.).

Download Sample Papers of Lateral Flow Assay Market spread across 219 Pages, 12 Companies and Supported with 180 Tables and 42 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=510469 .

The Lateral flow assay market report analyzes various types of kits & reagents and their adoption pattern. It aims at estimating market size and future growth potential of global lateral flow assay market for different segments like product, application, technique, end user, and region. Report also includes an in-depth competitive analysis of key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Target Audience:

  • Manufacturers and distributors of lateral flow assay kits & devices
  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
  • Pharmaceutical and biotechnology companies
  • Research institutes
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Lateral flow assay, also known as immunochromatographic assays, are simple devices intended to detect presence (or absence) of a target analyte in a sample (matrix). Factiva, and Avention, and annual reports of companies have been used to identify and collect information useful for study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

Interested in this report, Get More Information on Lateral Flow Assay Market Research now at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=510469 .

The lateral flow assay market segmented into clinical/point-of-care testing, veterinary diagnostics, food safety and environmental testing, and drug development & quality control testing. Food safety and environmental testing segment expected to grow at highest CAGR during forecast period. High growth of this segment driven by shifting of food & beverage industry from lab-based conventional microbiology techniques to rapid lateral flow assay tests.

Premium Insights

1 Lateral Flow Assays: Market Overview

2 Lateral Flow Assays Market: Developed vs Developing Countries

3 Geographic Snapshot: Lateral Flow Assays Market, 2016

4 Geographic Mix: Lateral Flow Assays Market

5 Asia-Pacific: Lateral Flow Assays Market, By Application

Some of the major market players in the lateral flow assay market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Johnson & Johnson (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and PerkinElmer, Inc. (U.S.).

Click now for more Details, Queries and Discount and Other Information on this study “Lateral Flow Assay Market by Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwich), End User - Global Forecast to 2022research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=510469 .

Geographically, lateral flow assay market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2016, North America held largest share of this market, and this is primarily attributed to the presence of a highly developed healthcare system, rising geriatric population, increasing incidence of chronic diseases, quick adoption of new innovative products, and a large number of lateral flow assay kits manufacturing companies in this region.

The global lateral flow assay market by end user is segmented into hospitals and clinics, home care, diagnostic laboratories, pharmaceutical & biotechnology companies, and other end users. In 2016, the hospitals and clinics segment accounted for the largest share of the market.